Your browser doesn't support javascript.
loading
Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.
Williams, Gregory P; Yu, Esther Dawen; Shapiro, Kendra; Wang, Eric; Freuchet, Antoine; Frazier, April; Lindestam Arlehamn, Cecilia S; Sette, Alessandro; da Silva Antunes, Ricardo.
Afiliación
  • Williams GP; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Yu ED; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Shapiro K; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Wang E; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Freuchet A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Frazier A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Lindestam Arlehamn CS; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
  • Sette A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; University of California San Diego School of Medicine, La Jolla, San Diego, CA, USA.
  • da Silva Antunes R; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA. Electronic address: rantunes@lji.org.
Hum Immunol ; 85(3): 110770, 2024 May.
Article en En | MEDLINE | ID: mdl-38433036
ABSTRACT
Post-acute sequelae of COVID-19 (PASC), or Long COVID, is a chronic condition following acute SARS-CoV-2 infection. Symptoms include exertion fatigue, respiratory issues, myalgia, and neurological manifestations such as 'brain fog,' posing concern for their debilitating nature and potential role in other neurological disorders. However, the underlying potential pathogenic mechanisms of the neurological complications of PASC is largely unknown. Herein, we investigated differences in antigen-specific T cell responses from the peripheral blood towards SARS-CoV-2, latent viruses, or neuronal antigens in 14 PASC individuals with neurological manifestations (PASC-N) versus 22 individuals fully recovered from COVID-19. We employed Activation Induced Marker (AIM), ICS and FluoroSpot assays to determine the specificity and magnitude of CD4+ and CD8+ T cell responses towards SARS-CoV-2 (Spike and rest of proteome), latent viruses (CMV, EBV), and several neuronal antigens. Overall, we observed similar antigen-specific T cell frequencies and cytokine effector T cell responses between PASC donors compared to recovered controls for all antigens tested (viral or autoantigen) in both CD4+ and CD8+ T cell compartments. Our findings suggest that PASC-N does not appear to be associated with changes in antigen-specific T cell responses towards a subset of disease-relevant targets, but more studies in a larger cohort are needed to confirm these unaltered responses.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / SARS-CoV-2 / COVID-19 / Síndrome Post Agudo de COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Immunol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / SARS-CoV-2 / COVID-19 / Síndrome Post Agudo de COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Immunol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos